vs
亚什兰（ASH）与Organogenesis Holdings Inc.（ORGO）财务数据对比。点击上方公司名可切换其他公司
亚什兰的季度营收约是Organogenesis Holdings Inc.的10.4倍（$386.0M vs $37.2M），亚什兰同比增速更快（-4.7% vs -57.1%），过去两年亚什兰的营收复合增速更高（-18.1% vs -46.5%）
亚什兰是一家总部位于美国特拉华州威尔明顿的化工企业，1924年始创于肯塔基州亚什兰市，最初以炼油业务起家，1994年迁至现总部。公司拥有多个业务板块，覆盖化工中间体与溶剂、复合材料、工业特种化学品、个人及家居护理、制药、食品饮料以及农业相关领域，2017年之前曾是胜牌润滑油的主要生产商。
Organogenesis Holdings Inc.是一家领先的再生医学企业，专注于开发、生产用于伤口护理、外科修复、运动医学和皮肤病领域的先进治疗产品，主要服务美国及部分国际市场的医疗机构与患者，提供经临床验证的医疗解决方案。
ASH vs ORGO — 直观对比
营收规模更大
ASH
是对方的10.4倍
$37.2M
营收增速更快
ASH
高出52.4%
-57.1%
两年增速更快
ASH
近两年复合增速
-46.5%
损益表 — Q1 FY2026 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $386.0M | $37.2M |
| 净利润 | $-12.0M | — |
| 毛利率 | 27.2% | 30.8% |
| 营业利润率 | -1.6% | -185.1% |
| 净利率 | -3.1% | — |
| 营收同比 | -4.7% | -57.1% |
| 净利润同比 | 92.7% | — |
| 每股收益（稀释后） | $-0.26 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASHORGO
| Q1 26 | — | $37.2M | ||
| Q4 25 | $386.0M | $225.6M | ||
| Q3 25 | $477.0M | $150.9M | ||
| Q2 25 | $463.0M | $101.0M | ||
| Q1 25 | $479.0M | $86.7M | ||
| Q4 24 | $405.0M | $126.7M | ||
| Q3 24 | $521.0M | $115.2M | ||
| Q2 24 | $544.0M | $130.2M |
净利润ASHORGO
| Q1 26 | — | — | ||
| Q4 25 | $-12.0M | $43.7M | ||
| Q3 25 | $31.0M | $21.6M | ||
| Q2 25 | $-742.0M | $-9.4M | ||
| Q1 25 | $31.0M | $-18.8M | ||
| Q4 24 | $-165.0M | $7.7M | ||
| Q3 24 | $17.0M | $12.3M | ||
| Q2 24 | $6.0M | $-17.0M |
毛利率ASHORGO
| Q1 26 | — | 30.8% | ||
| Q4 25 | 27.2% | — | ||
| Q3 25 | 33.3% | — | ||
| Q2 25 | 28.5% | — | ||
| Q1 25 | 30.7% | 72.6% | ||
| Q4 24 | 27.4% | 75.5% | ||
| Q3 24 | 33.2% | 76.7% | ||
| Q2 24 | 34.2% | 77.6% |
营业利润率ASHORGO
| Q1 26 | — | -185.1% | ||
| Q4 25 | -1.6% | 28.1% | ||
| Q3 25 | 12.8% | 13.7% | ||
| Q2 25 | -152.9% | -12.5% | ||
| Q1 25 | 10.6% | -30.9% | ||
| Q4 24 | -44.2% | 8.1% | ||
| Q3 24 | 6.1% | 5.4% | ||
| Q2 24 | -11.2% | -10.7% |
净利率ASHORGO
| Q1 26 | — | — | ||
| Q4 25 | -3.1% | 19.4% | ||
| Q3 25 | 6.5% | 14.3% | ||
| Q2 25 | -160.3% | -9.3% | ||
| Q1 25 | 6.5% | -21.7% | ||
| Q4 24 | -40.7% | 6.1% | ||
| Q3 24 | 3.3% | 10.7% | ||
| Q2 24 | 1.1% | -13.1% |
每股收益（稀释后）ASHORGO
| Q1 26 | — | — | ||
| Q4 25 | $-0.26 | $0.31 | ||
| Q3 25 | $0.83 | $0.11 | ||
| Q2 25 | $-16.21 | $-0.10 | ||
| Q1 25 | $0.65 | $-0.17 | ||
| Q4 24 | $-3.50 | $0.05 | ||
| Q3 24 | $0.34 | $0.09 | ||
| Q2 24 | $0.12 | $-0.13 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $304.0M | $91.4M |
| 总债务越低越好 | $1.4B | — |
| 股东权益账面价值 | $1.9B | — |
| 总资产 | $4.5B | $520.0M |
| 负债/权益比越低杠杆越低 | 0.74× | — |
8季度趋势，按日历期对齐
现金及短期投资ASHORGO
| Q1 26 | — | $91.4M | ||
| Q4 25 | $304.0M | $93.7M | ||
| Q3 25 | $215.0M | $63.7M | ||
| Q2 25 | $207.0M | $73.1M | ||
| Q1 25 | $168.0M | $110.0M | ||
| Q4 24 | $219.0M | $135.6M | ||
| Q3 24 | $300.0M | $94.3M | ||
| Q2 24 | $399.0M | $89.9M |
总债务ASHORGO
| Q1 26 | — | — | ||
| Q4 25 | $1.4B | — | ||
| Q3 25 | $1.4B | — | ||
| Q2 25 | $1.4B | — | ||
| Q1 25 | $1.3B | — | ||
| Q4 24 | $1.3B | — | ||
| Q3 24 | $1.3B | $62.3M | ||
| Q2 24 | $1.3B | $63.8M |
股东权益ASHORGO
| Q1 26 | — | — | ||
| Q4 25 | $1.9B | $300.1M | ||
| Q3 25 | $1.9B | $255.1M | ||
| Q2 25 | $1.9B | $233.2M | ||
| Q1 25 | $2.6B | $242.9M | ||
| Q4 24 | $2.6B | $262.9M | ||
| Q3 24 | $2.9B | $278.5M | ||
| Q2 24 | $3.0B | $263.5M |
总资产ASHORGO
| Q1 26 | — | $520.0M | ||
| Q4 25 | $4.5B | $598.7M | ||
| Q3 25 | $4.6B | $509.8M | ||
| Q2 25 | $4.6B | $461.1M | ||
| Q1 25 | $5.2B | $467.4M | ||
| Q4 24 | $5.2B | $497.9M | ||
| Q3 24 | $5.6B | $446.3M | ||
| Q2 24 | $5.7B | $443.2M |
负债/权益比ASHORGO
| Q1 26 | — | — | ||
| Q4 25 | 0.74× | — | ||
| Q3 25 | 0.73× | — | ||
| Q2 25 | 0.73× | — | ||
| Q1 25 | 0.52× | — | ||
| Q4 24 | 0.51× | — | ||
| Q3 24 | 0.47× | 0.22× | ||
| Q2 24 | 0.45× | 0.24× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $125.0M | — |
| 自由现金流经营现金流 - 资本支出 | $111.0M | — |
| 自由现金流率自由现金流/营收 | 28.8% | — |
| 资本支出强度资本支出/营收 | 3.6% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $200.0M | — |
8季度趋势，按日历期对齐
经营现金流ASHORGO
| Q1 26 | — | — | ||
| Q4 25 | $125.0M | $39.4M | ||
| Q3 25 | $40.0M | $3.1M | ||
| Q2 25 | $115.0M | $-32.9M | ||
| Q1 25 | $9.0M | $-19.9M | ||
| Q4 24 | $-30.0M | $10.9M | ||
| Q3 24 | $80.0M | $8.7M | ||
| Q2 24 | $127.0M | $4.7M |
自由现金流ASHORGO
| Q1 26 | — | — | ||
| Q4 25 | $111.0M | $34.8M | ||
| Q3 25 | $6.0M | $844.0K | ||
| Q2 25 | $95.0M | $-36.5M | ||
| Q1 25 | $-12.0M | $-23.6M | ||
| Q4 24 | $-53.0M | $7.6M | ||
| Q3 24 | $42.0M | $6.1M | ||
| Q2 24 | $98.0M | $2.9M |
自由现金流率ASHORGO
| Q1 26 | — | — | ||
| Q4 25 | 28.8% | 15.4% | ||
| Q3 25 | 1.3% | 0.6% | ||
| Q2 25 | 20.5% | -36.1% | ||
| Q1 25 | -2.5% | -27.2% | ||
| Q4 24 | -13.1% | 6.0% | ||
| Q3 24 | 8.1% | 5.3% | ||
| Q2 24 | 18.0% | 2.2% |
资本支出强度ASHORGO
| Q1 26 | — | — | ||
| Q4 25 | 3.6% | 2.1% | ||
| Q3 25 | 7.1% | 1.5% | ||
| Q2 25 | 4.3% | 3.6% | ||
| Q1 25 | 4.4% | 4.2% | ||
| Q4 24 | 5.7% | 2.7% | ||
| Q3 24 | 7.3% | 2.2% | ||
| Q2 24 | 5.3% | 1.4% |
现金转化率ASHORGO
| Q1 26 | — | — | ||
| Q4 25 | — | 0.90× | ||
| Q3 25 | 1.29× | 0.14× | ||
| Q2 25 | — | — | ||
| Q1 25 | 0.29× | — | ||
| Q4 24 | — | 1.43× | ||
| Q3 24 | 4.71× | 0.71× | ||
| Q2 24 | 21.17× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASH
| Personal Care And Household | $123.0M | 32% |
| Other | $120.0M | 31% |
| Specialty Additives | $36.0M | 9% |
| Intermediates And Solvents | $31.0M | 8% |
| Personal Care | $30.0M | 8% |
| Life Sciences | $27.0M | 7% |
| Intermediates | $19.0M | 5% |
ORGO
暂无分部数据
